Last update :
19/11/2024
Antibiotic   Colistin mesilate sodium  
injection
aerosol
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Alfacolin Argentina
Alficetin Argentina
Colent Chile
Colimicina Italy, Spain
Colimycin Denmark, Norway, Turkey
Colimycine France, Luxembourg, Morocco, Netherlands, Tunisia
Colismet Peru
Colisti Ject Egypt
Colistimetal sodic Romania
Colistimetato de sodio Chile, Peru, Spain
Colistimethate Canada, Great Britain, United States of America
Colistin Austria, Greece, New Zealand, Poland
Colistina Argentina, Portugal
Colistineb Belgium
Colistyn Argentina
Colixin Portugal
Colomycin Canada, Great Britain, Ireland, Malaysia, United States of America
Coly-Mycin Australia, United States of America
Cotrelan Argentina
Dicupal Chile
Elistin Peru
Kolisod Turkey
Nolisin Argentina
Promixin Great Britain, Ireland, Norway
Toliscrin Argentina
References   injection   References : Colistin mesilate sodium  
Type Publication
1201 Journal Yuhas EM, Lofton FT, Rosenberg HA, Mayron D, Baldinus JG.
Cimetidine hydrochloride compatibility III: Room temperature stability in drug admixtures.
Am J Hosp Pharm 1981 ; 38: 1919-1922.
2285 Journal Wallace SJ, Li J, Rayner CR, Coulthard K, Nation RL.
Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patients.
Antimicrob Agents Chemother 2008 ; 52, 9: 3047-3051.
2550 Journal Roberts GW, Rossi S.O.P.
Compatibility of nebulizer solutions
Aust J Hosp Pharm 1993 ; 23: 35-37.
2783 Journal Abdulla A,.van Leeuwen R.W.F, de Vries Schultink A.H.M,.Koch B.C.P.
Stability of colistimethate sodium in a disposable elastomeric infusion device.
Int J Pharm 2015 ; 486; 1-2: 367-369.
3254 Journal Housman S.T, Tessier P.R, Nicolau D.P, Kuti J.L.
Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration
Am J Health-Syst Pharm 2011 ; 68: 2265-2270.
3360 Journal Healan A. M, Gray W, Fuchs E.J, Griffiss J.M, Salata R.A, Blumer J.
Stability of Colistimethate Sodium in Aqueous Solution.
Antimicrob Agents Chemother 2012 ; 56:6432-6433.
3674 Manufacturer Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016
3827 Poster Ghazi I.M, Hamada Y, Nicolau D.P.
Compatibility of tedizolid phosphate with selected intravenous drugs via simulated Y-site conditions.
ASHP Midyear 2015
3828 Poster Thabit A.K, Hamada Y, Nicolau D.P.
Ceftozolane/tazobactam physical compatibility during simulated Y-site administration.
ASHP Midyear 2015
3829 Poster So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L.
Compatibility of isavunazonium sulfate during simulated Y-site administration.
ASHP Midyear 2015
3997 Journal Katip W.
Visual compatibility of colistin injection with other antibiotics during simulated Y-site administration.
Am J Health-Syst Pharm 2017 ; 74:14 : 1099-1102
4055 Journal Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D.
Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2018 , 75, 1:36-44
4145 Journal Asempa T.E, Avery L.M, Kidd J.M, Kuti J.L, Nicolau D.P.
Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2018 ;75,14:1048-1056
4178 Journal Post T.E, Kamerling I, van Rossen R, Burggraaf J, Stevens J, Dijkmans A, Heijerman H, Touw D, van Velzen A, Wilms E.
Colistin methanesulfonate infusion solutions are stable over time and suitable for home administration.
EJHP 2017 ; 25, e2
4319 Journal Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G.
Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs.
Hosp Pharm 2020 ; 55, 5: 332-337.
4434 Journal Avery L.M, Chen, I.H, Reyes, S, Nicolau, D.P, Kuti J.L.
Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration.
Clin Ther 2019 ; 41, 10: 2162-2170.
4438 Journal Stawny M, Gostyńska A, Nadolna M, Jelińska A.
Safe Practice of Y-Site Drug Administration: The Case of Colistin and Parenteral Nutrition
Pharmaceutics 2020 ; 12: 292
4528 Journal Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N.
Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration.
Int J Pharm Compound 2021 ;25,1:52-61
4801 Journal Ruiz V, Yuwei Shen Y, Abouelhassan Y, Fouad A, Nicolau D, Kuti J.
Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2024 ;51,1:

  Mentions Légales